Rika Shinagawa
Rika Shinagawa publishes mostly in Neurology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Neuroinflammation and Neurodegeneration Mechanisms, S100 Proteins and Annexins and Neuroscience and Neuropharmacology Research.
- World rank
- #6,659,409 of 7,710,434 ranked researchers
- Rank in Japan
- #276,262 of 383,136
- Works
- 17
- Citations
- 317
- Citations per work
- 18.6
What does Rika Shinagawa research?
Rika Shinagawa's work is mostly in Neuroscience (31%), Medicine (26%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences846.2%
- Everything else528.1%
- Health Sciences425.7%
- Medicine425.7%
- 1Neurology20% of their works
- 2Molecular Biology15% of their works
- 3Cellular and Molecular Neuroscience10% of their works
- 4Physiology10% of their works
- 5Neurology8% of their works
- 6Pulmonary and Respiratory Medicine8% of their works
Research topics
- Neuroinflammation and Neurodegeneration Mechanisms
- S100 Proteins and Annexins
- Neuroscience and Neuropharmacology Research
- Alzheimer's disease research and treatments
- Blood properties and coagulation
- Neurological Disease Mechanisms and Treatments
- Plant Stress Responses and Tolerance
- Genetics and Plant Breeding
Which keywords describe Rika Shinagawa's research?
The keywords of their largest research topics: Neurodegeneration, Innate Immunity, Neuroinflammation, Oxidative Stress, Astrocytes, Microglia, Inflammation and Neurotransmission.
- Reactive Oxygen Species
- Cultivar Evaluation
- Vascular Cognitive Impairment
- Transglutaminases
- Fibrinogen
- Synaptic Plasticity
- Neurotransmission
- Microglia
- Oxidative Stress
- Innate Immunity
- Neurodegeneration
- Neuroinflammation
- Astrocytes
- Inflammation
- S100 Proteins
- Amyloid Hypothesis
- Tau Pathology
- Cerebral Hypoperfusion
- Antioxidants
- Genotype-by-Environment Interaction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Neurodegeneration123 topics
- Innate Immunity92 topics
- Neuroinflammation82 topics
- Oxidative Stress63 topics
- Astrocytes51 topic
- Microglia51 topic
- Inflammation41 topic
- Neurotransmission41 topic
- S100 Proteins41 topic
- Synaptic Plasticity41 topic
- Amyloid Hypothesis31 topic
- Fibrinogen31 topic
- Tau Pathology31 topic
- Transglutaminases31 topic
- Cerebral Hypoperfusion21 topic
- Vascular Cognitive Impairment21 topic
- Antioxidants11 topic
- Cultivar Evaluation11 topic
- Genotype-by-Environment Interaction11 topic
- Reactive Oxygen Species11 topic
Where does Rika Shinagawa work?
Rika Shinagawa's main affiliation in the publication record is Ono Pharmaceutical (Japan), Japan.
How many publications and citations does Rika Shinagawa have?
OpenAlex counts 17 works and 317 citations for Rika Shinagawa, an h-index of 9, ranking #6,659,409 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rika Shinagawa. Posts are plain text and can be reported.